Stepan Company (NYSE: SCL) reported first‑quarter 2026 results with net sales of $604.5 million, a 2 % year‑over‑year increase from $593.3 million in Q1 2025. The company missed consensus revenue estimates of $612.95 million, falling short by about 1.4 %.
Operating loss of $49.6 million translated into a net loss of $41.4 million. GAAP diluted earnings per share were –$1.81, but adjusted diluted EPS were $0.45, beating the consensus estimate of $0.44 by $0.01 (2.3 %). The adjusted EPS beat was driven by disciplined cost management and the early impact of Project Catalyst, which has already begun to reduce restructuring charges.
Margin compression was most pronounced in the Surfactants segment, where higher oleochemical costs and production timing differences squeezed profitability. Polymers showed mixed results, with a 30 % volume increase but a 14 % decline in operating income due to raw‑material cost inflation. Specialty Products experienced a volume surge but saw a 14 % drop in operating income, reflecting higher input costs.
Management highlighted the ongoing Project Catalyst program, a two‑year operational and efficiency initiative launched in February 2026 that targets approximately $100 million in pre‑tax savings. The program includes the closure of the Fieldsboro, NJ site and decommissioning of assets in Illinois and the UK, with restructuring charges for 2026 expected to be between $70 million and $80 million, largely front‑loaded into Q1 2026.
Stephan maintained its full‑year guidance, signaling confidence in its ability to deliver adjusted EBITDA growth and positive free cash flow in 2026 despite market challenges. Investors reacted positively, citing the adjusted EPS beat and the strategic focus of Project Catalyst.
CEO F. Quinn Stepan Jr. said, "Despite the challenges faced this quarter, our strategic initiatives are positioning us for long‑term growth. We are committed to optimizing our operations and enhancing shareholder value." President and CEO Luis E. Rojo added, "Project Catalyst is not a short‑term cost reduction program alone. It is a strategic transformation designed to enhance the competitiveness of our cost base while preserving customer service and growth flexibility." He also noted, "We believe we are well positioned to deliver adjusted EBITDA growth and positive free cash flow in 2026 despite the ongoing market challenges."
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.